SRTS

Sensus Healthcare, Inc
Data: 2026-05-18
$3.48
Price
-3.60%
Change
$5.92
52W High
$2.82
52W Low

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Quick Stats
May 18, 2026

52.3

AI Score

HOLD

0.25

Volume Ratio

May 07, 2026

Next Earnings

17

+ve Days (30d)

11

-ve Days (30d)

SRTS Stock Summary

Last updated May 18, 2026

SRTS is currently trading at $3.48, positioned below its 200-day moving average of $3.93, suggesting bearish momentum. The stock has a 52-week range of $2.82 to $5.92.

Technical Analysis: The 50-day moving average stands at $4.01, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.28, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.068, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates SRTS at 52.3/100 with a HOLD recommendation.

SRTS (Sensus Healthcare, Inc) Indicators

Last updated May 18, 2026

Indicator Value
RSI(14) 40.28
CMF (20) 0.068
ROC (10) -11.364
ADX (14) 17.966
Indicator Value
MACD (12,26,9) -0.174
AROONOSC (14) -7.143
WILLAMS %R (14) -52.74
MFI (14) 50.852
SRTS Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

SRTS Price vs Max Options Open Interest
SRTS Max Change In Options Open Interest

SRTS Options - Sort by Max open Interest (near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

SRTS Daily Out of Money Options - Sort by Max open Interest (near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

SRTS Daily In the Money Options - Sort by Max open Interest (near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

SRTS Most Active Options by Volume(near term)

18th May 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Sensus Healthcare, Inc is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

SRTS Moving Averages Analysis

SRTS (Sensus Healthcare, Inc) Simple Moving Averages

Moving Averages are last updated May 18, 2026

Days MA
10 3.61
20 3.78
30 4.0
50 4.01
100 4.26
200 3.93

SRTS Fundamental Analysis

P/E (Forward) 400
P/E (Trailing) --
Market Cap ($) 59.6 million
Earnings/Share ($) -0.47
Net Proft Margin (%) -0.2809
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.2933
EPS Estimate Next Year ($) 0.09
WallStreet Target Price ($) 6.25
Most Recent Quarter